Viewing Study NCT01992367


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-02-26 @ 8:12 PM
Study NCT ID: NCT01992367
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2013-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003
Sponsor: ASLAN Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module